Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention

October 9, 2020 updated by: Memorial Sloan Kettering Cancer Center

Evaluation of an Anxiety Intervention for Older Adults With Cancer and Informal Caregivers of Older Adults With Cancer

The purpose of this study is to examine the feasibility and acceptability of and patient adherence to a telephone-administered cognitive-behavioral therapy intervention for anxiety in older adults (65 years and older) with cancer and their primary informal caregiver. This study will also examine whether the intervention has a clinically significant impact on patient anxiety (primary outcome) and depression, distress, and quality of life (secondary outcomes).

Study Overview

Status

Completed

Detailed Description

This study is a single arm pre-post evaluation of a six-session telephone-administered cognitive-behavioral therapy (CBT) intervention for anxiety in older adults with cancer and their primary informal (unpaid) caregiver. The primary purposes of this study are to evaluate the feasibility of the intervention and study procedures, acceptability of the intervention to older adults with cancer and their primary informal caregiver, and patient and caregiver adherence to the intervention. The secondary purpose is to examine changes in patient and caregiver anxiety, depression, distress, and quality of life pre to post intervention to determine whether the intervention has a clinically significant impact on these outcomes. Anxiety is the primary outcome; depression, distress, and quality of life are secondary outcomes. Patients will be 65 years of age or older and will be recruited from the myeloma, lung, lymphoma, gynecologic, and gastrointestinal cancer clinics at a single institution. Study measures will be administered by telephone prior to initiating the intervention (pre-intervention) and following intervention completion (post-intervention).

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10065
        • Weill Medical College of Cornell University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient age 65 years or older
  2. Diagnosis of cancer
  3. Patient and/or caregiver score of 8 or higher on the anxiety subscale of the Hospital Anxiety and Depression Scale
  4. A primary informal caregiver who is willing and able to participate
  5. Patient and caregiver are able to communicate over the telephone
  6. Caregiver is age 21 years or older.

Exclusion Criteria:

  1. Patient or caregiver is not fluent in English
  2. Patient or caregiver is too weak or cognitively impaired to participate in the intervention
  3. Patient or caregiver has received CBT since the patient's cancer diagnosis
  4. Patient or caregiver has an active major psychiatric condition such as schizophrenia
  5. Patient only experiences anxiety in the context of a specific medical procedure
  6. Patient or caregiver endorses active suicidal ideation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Managing Anxiety from Cancer (MAC)
Older adults with cancer and their primary informal caregiver will receive a six-session cognitive-behavior therapy intervention administered over the telephone by a trained study interventionist. The intervention is administered weekly and each session is 45-50 minutes in length. Patients and caregivers will receive the intervention independently and from separate therapists.
The intervention consists of six telephone-administered sessions. Session topics include psychoeducation on anxiety, behavioral strategies for managing anxiety, cognitive restructuring, communication skills training, acceptance techniques (patient only), problem-solving strategies (caregiver only), and planning for future anxiety. Session content is tailored for older adults and caregivers of older adults with cancer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention feasibility
Time Frame: Post-intervention (6-8 weeks after baseline)
Attrition rates
Post-intervention (6-8 weeks after baseline)
Intervention acceptability
Time Frame: Post-intervention (6-8 weeks after baseline)
Likert scale ratings of perceived helpfulness and readability of the intervention
Post-intervention (6-8 weeks after baseline)
Patient/caregiver adherence
Time Frame: Post-intervention (6-8 weeks after baseline)
Sum of number of intervention exercises completed with number of sessions completed by patients and caregivers
Post-intervention (6-8 weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety from baseline to post-intervention
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Anxiety sub-scale of the Hospital Anxiety and Depression Scale
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Change in distress from baseline to post-intervention
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Distress Thermometer
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Emotional health-related quality of life
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Functional Assessment of Cancer Therapy-General: Emotional Quality of Life Sub-Scale; Caregiver Quality of Life-Cancer
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Change in depression from baseline to post-intervention
Time Frame: Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)
Depression sub-scale of the Hospital Anxiety and Depression Scale
Baseline (1-2 weeks after enrollment) and Post-intervention (6-8 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kelly M Trevino, PhD, Weill Medical College of Cornell University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2016

Primary Completion (ACTUAL)

July 2, 2020

Study Completion (ACTUAL)

July 2, 2020

Study Registration Dates

First Submitted

April 12, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (ESTIMATE)

April 21, 2016

Study Record Updates

Last Update Posted (ACTUAL)

October 14, 2020

Last Update Submitted That Met QC Criteria

October 9, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 19-280

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Managing Anxiety from Cancer (MAC)

3
Subscribe